Petra Financial Advisors Inc. Invests $208,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Petra Financial Advisors Inc. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 398 shares of the medical equipment provider’s stock, valued at approximately $208,000.

Other large investors also recently modified their holdings of the company. Massachusetts Financial Services Co. MA purchased a new position in Intuitive Surgical in the 3rd quarter valued at approximately $558,807,000. Proficio Capital Partners LLC grew its stake in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares in the last quarter. FMR LLC grew its stake in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $313,769,000. Finally, Wilmington Savings Fund Society FSB grew its stake in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.9 %

Shares of NASDAQ:ISRG opened at $488.80 on Tuesday. The company has a market cap of $174.10 billion, a price-to-earnings ratio of 76.26, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company has a 50-day moving average price of $566.38 and a 200-day moving average price of $531.96. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Raymond James boosted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $610.19.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.